A detailed history of Quarry LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Quarry LP holds 6,003 shares of TGTX stock, worth $143,051. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,003
Previous 5,500 9.15%
Holding current value
$143,051
Previous $83.7 Million 27.66%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$13.32 - $19.19 $6,699 - $9,652
503 Added 9.15%
6,003 $107 Million
Q1 2024

May 15, 2024

BUY
$13.02 - $21.3 $71,610 - $117,150
5,500 New
5,500 $83.7 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $3.46B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.